Display options
Cite
Bhagat PR, Agrawal KU, Tandel D. Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma. J Curr Glaucoma Pract. 2016;10(2):39-48doi: 10.5005/jp-journals-10008-1200.
Bhagat, P. R., Agrawal, K. U., & Tandel, D. (2016). Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma. Journal of current glaucoma practice, 10(2), 39-48. https://doi.org/10.5005/jp-journals-10008-1200
Bhagat, Purvi R, et al. "Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma." Journal of current glaucoma practice vol. 10,2 (2016): 39-48. doi: https://doi.org/10.5005/jp-journals-10008-1200
Bhagat PR, Agrawal KU, Tandel D. Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma. J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48. doi: 10.5005/jp-journals-10008-1200. Epub 2016 Aug 05. PMID: 27536046; PMCID: PMC4981657.
Copy Download .nbib Format: NLM
Share it on

J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48. doi: 10.5005/jp-journals-10008-1200. Epub 2016 Aug 05.

Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma.

Journal of current glaucoma practice

Purvi R Bhagat, Kushal U Agrawal, Dipali Tandel

Affiliations

  1. Associate Professor, Department of Glaucoma Clinic, M&J Western Regional Institute of Ophthalmology, Ahmedabad, Gujarat, India.
  2. Resident, Department of Glaucoma, M&J Western Regional Institute of Ophthalmology, Ahmedabad, Gujarat, India.
  3. Student, Department of Glaucoma, M&J Western Regional Institute of Ophthalmology, Ahmedabad, Gujarat, India.

PMID: 27536046 PMCID: PMC4981657 DOI: 10.5005/jp-journals-10008-1200

Abstract

PURPOSE: To study the effect of injection bevacizumab on iris neovascularization (NVI) and angle neovascularization (NVA) and compare its efficacy in terms of visual outcome, NVI, NVA, and intraocular pressure (IOP) control between intracameral, intravitreal, and combined use.

MATERIALS AND METHODS: This was a prospective study conducted at a tertiary center for patients of neovascular glaucoma (NVG), including 20 eyes of 20 patients. After thorough evaluation, patients were divided into three groups: Intracameral, intravitreal, or combined, according to the route of injection bevacizumab required.

RESULTS: About 30% of patients belonged to the age group 51 to 60 years of which 80% were female. In 50%, vein occlusion was the cause of NVG, and 50% needed intravitreal injection bevacizumab. After 4th week of injection 90% and after 12th week 60% were found to have absence of NVI. Patients who had IOP in the range of 11 to 20 mm Hg and 21 to 30 mm Hg showed lower IOP as compared to other groups. But no significant difference was noted in higher IOP groups. Only two patients required antiglaucoma surgery. There was no statistically significant difference in visual outcomes in any groups. In all routes, there were statistically significant changes in NVI and NVG in the 1st and 4th weeks.

CONCLUSION: The effect of injection in all routes deteriorates after 8 weeks. Intracameral route of injection is found to be most effective in terms of control of IOP. There was no statistically significant difference in terms of improvement in best corrected visual acuity (BCVA) in any route. Injection bevacizumab is effective and statistically significant in reducing the need of antiglaucoma surgery for NVG patients. How to cite this article: Bhagat PR, Agrawal KU, Tandel D. Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma. J Curr Glaucoma Pract 2016;10(2):39-48.

Keywords: Anti-vascular endothelial growth factor; Bevacizumab; Glaucoma; Neovascular.

References

  1. Br J Ophthalmol. 2006 Mar;90(3):262-7 - PubMed
  2. Ophthalmology. 1983 May;90(5):488-506 - PubMed
  3. Ophthalmology. 2005 Jun;112(6):1035-47 - PubMed
  4. Br J Ophthalmol. 1971 Jul;55(7):444-50 - PubMed
  5. Middle East Afr J Ophthalmol. 2009 Apr;16(2):75-9 - PubMed
  6. Retina. 2006 Mar;26(3):352-4 - PubMed
  7. Ophthalmology. 1984 Apr;91(4):315-20 - PubMed
  8. Acta Ophthalmol (Copenh). 1971;49(2):301-7 - PubMed
  9. Retina. 2008 May;28(5):696-702 - PubMed
  10. Science. 1989 Dec 8;246(4935):1306-9 - PubMed
  11. Am J Pathol. 1994 Sep;145(3):574-84 - PubMed
  12. Eur J Ophthalmol. 2008 Mar-Apr;18(2):255-62 - PubMed

Publication Types